Therapie und Prognose der oberen Einflußstauung beim anaplastischen kleinzelligen Bronchuscarcinom

Translated title of the contribution: Treatment and prognosis of superior vena caval syndrome in small-cell anaplastic carcinoma of the lung

R. Joss, K. Salonen, A. Goldhirsch, K. Brunner

Research output: Contribution to journalArticle


One hundred and forty nine consecutive patients with small-cell anaplastic carcinoma of the lung were studied retrospectively. 19 patients (13%) presented with superior vena caval obstruction, 11 further patients (7%) developed this complication during the course of their disease. 16 patients presenting with superior vena caval syndrome were treated with chemotherapy alone and 13 patients responded. Due to suboptimal chemotherapy for current standards 7 of the 13 successfully treated patients (54%) relapsed after a median of 4.5 months. 3 patients were effectively retreated with another chemotherapy combination, 4 patients with radiation therapy. Superior vena caval obstruction is a frequent complication of small-cell anaplastic carcinoma of the lung. It can be treated effectively with combination chemotherapy.

Original languageGerman
Pages (from-to)385-389
Number of pages5
JournalKlinische Wochenschrift
Issue number8
Publication statusPublished - Apr 1981



  • Oat cell/drug therapy
  • Superior/carcinoma
  • Vena cava

ASJC Scopus subject areas

  • Medicine(all)

Cite this